FDA Drug Application (062512) for NYSTATIN by WOCKHARDT

Back to FDA Applications sponsored by WOCKHARDT

Application Number062512
Product Number001
FormSUSPENSION;ORAL
Dosage100,000 UNITS/ML
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AA Products in conventional dosage forms not presenting bioequivalence problems
Reference Drug
Drug NameNYSTATIN
Active IngredientNYSTATIN

Active IngredientCount
List of drugs with Active Ingredient NYSTATIN18


Back to FDA Applications sponsored by WOCKHARDT